Skip to navigation Skip to main content

Venetoclax (Venclexta)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews venetoclax (Venclexta), indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion who have received at least 1 prior therapy.

Topics:

Chronic Lymphocytic Leukemia Drug Information Hematologic Cancers Slideshows Stat Consult
  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next hm-slideshow in Slides